Tiziana Life Sciences Ltd (NASDAQ:TLSA) is set to present at the Biotech Showcase in San Francisco from January 8-10, 2024. The company's Chief Operating Officer and Chief Medical Officer, Dr. Matthew Davis, will lead the presentation titled "Intranasal Anti-CD3 mAb Therapy to Enable Breakthroughs in Neuroinflammatory and Neurodegenerative Diseases" on Monday, January 8th, at 9:30 am PST in Room Yosemite-C.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com